CLaret Embolic Protection ANd TAVI - Trial

NCT01833052 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-05-05

No results posted yet for this study

Summary

This prospective, randomized study was designed to investigate the benefit of using a Filter-Protection-Device (Claret MontageTM Dual Filter System) during transcatheter aortic valve implantation (TAVI) with a Medtronic CoreValve®.

Conditions

  • Frequency of Cerebral Perfusion Defects After TAVI
  • Size of Cerebral Perfusion Defects After TAVI

Interventions

DEVICE

TAVI (Medtronic CoreValve)

DEVICE

Claret-Filter

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-06-30
Completion
2015-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833052 on ClinicalTrials.gov